161672-76-0 Usage
General Description
The chemical (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-8-oxo-3-{(E)-[2-oxo-1-(2,2,2-trifluoroethyl)pyrrolidin-3-ylidene]methyl}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid is a complex organic compound with a bicyclic structure and various functional groups. It contains a thiazole ring with an amino group and a hydroxyimine group, an oxo group, a pyrrolidine ring with a carbonyl group, and a carboxylic acid group. (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-8-oxo-3-{(E)-[2-oxo-1-(2,2,2-trifluoroethyl)pyrrolidin-3-ylidene]methyl}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid is a potential drug candidate with antibacterial properties, potentially targeting bacterial protein synthesis. Its intricate structure suggests its potential for specific interactions with biological targets, making it of interest for further study and potential pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 161672-76-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,6,7 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 161672-76:
(8*1)+(7*6)+(6*1)+(5*6)+(4*7)+(3*2)+(2*7)+(1*6)=140
140 % 10 = 0
So 161672-76-0 is a valid CAS Registry Number.
161672-76-0Relevant articles and documents
Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci
Heinze-Krauss, Ingrid,Angehrn, Peter,Guerry, Philippe,Hebeisen, Paul,Hubschwerlen, Christian,Kompis, Ivan,Page, Malcolm G. P.,Richter, Hans G. F.,Runtz, Valérie,Stalder, Henri,Weiss, Urs,Wei, Chung-Chen
, p. 1864 - 1871 (2007/10/03)
The synthesis and structure-activity relationships of a new class of vinylcephalosporins substituted with a lactamyl residue (1) are described. These compounds show excellent activity against enterococci and retain the broad spectrum activity of third-gen